Ghrelin - A Possible Opportunity to Improve Appetite (Phase 3)

Göteborg University

Status and phase: Completed; Phase 3

Conditions: Cancer

Treatments: Drug: Ghrelin

Study type: Interventional

Funder types: Other

Identifiers

NCT00681486

kl4501123

Details and patient eligibility

About

The study is designed to evaluate whether ghrelin treatment can improve appetite in weight losing cancer patients.

Full description

Randomized study with follow up evaluations each month until preterminal state. Cancer patients will be randomised to either high dose or low dose of active treatment given as daily injection.

Enrollment: 30 estimated patients

Sex: All

Ages: 40 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Weight loss

Exclusion criteria

• Diabetes

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

30 participants in 2 patient groups

A, 1

Active Comparator group

Description:

Ghrelin

Treatment:

Drug: Ghrelin

Drug: Ghrelin

A, 2

Active Comparator group

Description:

Ghrelin.

Treatment:

Drug: Ghrelin

Drug: Ghrelin